Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
暂无分享，去创建一个
V. Pavone | M. Boccadoro | R. Mina | E. Zamagni | I. Vincelli | P. Musto | M. Cea | N. Giuliani | A. Gozzetti | L. Bertamini | C. Cellini | P. de Fabritiis | B. Gamberi | S. Aquino | S. Ronconi | N. Pescosta | S. Ballanti | L. De Rosa | M. Grasso | A. Palmas | D. Oddolo | D. Rota-Scalabrini | A. Belotti | L. Paris | Francesca Gay | A. Capra | F. Fioritoni | F. Gay | Daniela Oddolo